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A key phase in the emigration ofneutrophils is the increased adherence ofthese
cells to microvascular endothelial cells, initiated by the extravascular generation of
chemical mediators. In vitro studies suggest that chemoattractants, such as C5a,
FMLP, and leukotriene B4 (LT$4), may act in vivo by stimulating the expression of
the MacI glycoproteincomplexon the surface ofthe neutrophil within thevenule lumen
(1), whereas the macrophage-derived monokine, IL-1, may act by causing the ex-
pression ofadhesive molecules (endothelial leukocyte adhesion molecule [E-LAM])
onthe endothelialcell (2). Invivo and in vitro, the former process is rapid, whereas
the latter is slow in onset and protein biosynthesis dependent (2, 3). Furthermore,
neutrophil accumulation induced by C5a, FMLP, and LTB4 is associated with a
parallel time course of increased microvascular permeability, whereas little oedema
formation is observed in response toIL-1, suggesting differentmechanisms ofaction
in vivo (4, 5).
Recent in vitro studies have demonstrated that another macrophage-derived
monokine, TNF, enhances endothelial cell adhesiveness for neutrophils via the ex-
pression ofthe same membrane protein that is also induced by IL-1 (6). Incontrast
to IL-1, TNF has been reported to have stimulatory effects on neutrophils similar
to C5a, FMLP, and LTB4, including increased adherence viaexpression ofthe Mac
I glycoprotein complex (7). This unique spectrum of biological activities, plus the
amounts ofTNF that can be produced by macrophages in response to a microbial
stimulus (up to 2% of their total protein biosynthesis), have implicated TNF as a
putative mediator of the inflammatory reaction (8, 9).
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Animals.
￿
New Zealand white rabbits (2.5-3.5 kg) were purchased fromJanssen Phar-
maceutica, Beerse, Belgium.
Materials.
￿
BSA, bradykinin (Bk), Evansblue dye, N-FMLP, 2-mercaptopyridine-N-oxide
(MERC), Nitrogen mustard, and prostaglandin E2 (PGE2) were from Sigma Chemical Co.,
Poole, UK. Nembutal (pentobarbitone sodium, 60 mg/ml) was from Abbott Laboratories,
Paris, France. Plasmasteril (6% hydroxyethyl starch in 0.9% NaCl, sterile pyrogen free) was
from Fresenius A. G., Homburg, FRG. Percoll was from Pharmacia Fine Chemicals, Upp-
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sala, Sweden. Sterile pyrogen-free solutions of acid-citrate-dextrose (ACD) and isotonic sa-
line were from Travenol Laboratories, Lessines, Belgium. "'In C13 (2 mCi in 0.2 ml sterile
pyrogen-free 0.04 N hydrochloric acid) and 1251 human serum albumin (50 uCi/2 mg al-
bumin/ml sterile pyrogen-free isotonic saline) were from Amersham International, Amer-
sham, UK.
Prostacyclin (PG12) sodium salt was a gift from Dr. S. Moncada, Wellcome Research
Laboratories, Beckenham, UK.
Methods.
￿
TNF preparations were kindly donated by Dr. J. Tavernier, Biogent, Belgium.
Mouse and human recombinant TNF were expressed in Escherichia coli and purified to
homogeneity as described previously (10). Using the L929 cytotoxicity assay the specific ac-
tivity of mouse and human recombinant TNF preparations was 7.5 x 107 U/mg protein and
2.5 x 107 U/mg protein, respectively. LPS contamination was 36 ng/mg protein by Limulus
assay.
Preparation of "'In-labeled Neutrophils (4).
￿
Rabbit neutrophils (>90% pure) were harvested
from 72 ml ofcitrated blood by a two-layer discontinuous (40/60%) Percoll-plasma gradient
after initial red cell sedimentation with hydroxyethyl starch (3% final concentration). Neu-
trophils (5 x 101-2 x 108 cells) were incubated with "'In C13 (50-200 ACi) chelated to
MERC (40 /cg) for 15 min at room temperature. The labeled cells were washed twice and
resuspended in autologous citrated plasma.
Neutrophil infiltration and oedema formation in the rabbit back skin were measured as
the local accumulation of intravenously (marginal ear vein) injected "'In neutrophils and
'251 human serum albumin (5 ACi, mixed with 2 ml of a 2.5% Evans blue dye solution) (4).
Test agents were injected intradermally in 0.1-ml vol, each treatment having six replicates.
At the end of the experiment, animals were killed by an overdose ofpentobarbitone sodium,
the back skin was removed, the injection sites were excised, and were then counted in a gamma
counter with automatic spill-over correction (5005 Cobra; Packard Instrument Co. Inc.,
Downers Grove, IL).
Results were expressed in terms of number of "'In neutrophils by comparing skin sample
"'In counts with "'In counts per cell in preparations before intravenous injection. Exudate
volumes were expressed as microliters of plasma by dividing skin sample "5I counts by 1251
counts in 1 Al of plasma (4).
Intradermal injections were given according to a balanced site pattern and injection order
was based on a Latin square design. Results are shown as mean t SEM for the number
of rabbits indicated; one data unit being the mean of six replicates in each rabbit.
For neutrophil depletion studies, animals were injected with nitrogen mustard (1.75 mg/kg,
i.v.) 2 d before experimentation (11).
Results
Over a 30-min period mouse recombinant TNF (0.4-40 U/site, 3 x 10-16-3 x
10-14 mol/site) induced very little plasma leakage and neutrophil accumulation
when injected alone in rabbit skin (Figs. 1 and 2, left panels, open symbols). Coinjec-
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FIGURE 1.
￿
The effect of PGI2 infusion and
neutrophil depletion on mouse TNF-induced
plasma leakage. Open symbols are responses
to mouse TNF, FMLP, and Bk alone. Closed
symbols are responses to these mediators, but
mixed with PGE2 (3 x 10-'° mol/site). For
experimental details, see Materials and Meth-
ods. Results are the mean t SEM for six
rabbits.tion of a vasodilator substance (PGE2, 3 x 10-1° mol/site) resulted in substantial
oedema formation and neutrophil accumulation by these doses of mTNF (Figs . 1
and 2, closed symbols) . Neutrophil emigration and their accumulation in extravas-
cular tissue was confirmed by histological examination of sections of skin, injected
with combinations ofmTNF and PGE2 . PGE2 alone (3 x 10-1° mol/site) did not
induce leakage or cell accumulation .
Higher doses ofmouseTNF (up to 4,000 U/site, 3 x 10 -12 mol/site) did not re-
sult in anylarger responses . In all experimentsan established chemoattractant (FMLP,
5 x 10-11 mol/site) and a neutrophil-independent mediator of oedema formation
(Bk, 10-1° mol/site) were included for reference (11) .
As previously documented forFMLP, oedema formation inducedby mouseTNF
was completely abolished in animals made neutropenic by previous injection of
nitrogen mustard (Fig . 1, right panel) . Responses to Bk were not affected .
Infusion of PG12 (50 ng/kg/min, previously shown to have no effect on systemic
blood pressure, reference 12) almost completely suppressed mouseTNF andFMLP-
induced neutrophil accumulation and oedema formation . Bk-induced leakage was
not altered during PG12 infusion (Fig . 1, middle panel ; Fig. 2, right panel) . In the ex-
periments shown in Fig . 3, the 30-min flux of albumin and neutrophils was mea-
sured in inflammatory lesions of different age (0-6 h) . MouseTNF (40 U/site, 3 x
10-14 mol/site) or FMLP (5 x 10-11 mol/site) were injected intradermally at different
time intervals (-360-0 min ; Fig . 3, x-axis). At zero time, 1251 albumin and 111In
neutrophilswere injected intravenously . At this time, all intradermal sites were rein-
jected with PGE2 (3 x 10-1° mol/site) and plasma leakage and neutrophil emigra-
tion were measured over a30-min period . Fig. 3 showsthat FMLP-induced leakage
and cell accumulation were maximal in the first 30min and then gradually declined
to very low values by 4-6 h. The biological t1i2 ofFMLP (for both leakage and neu-
trophil emigration) was 50-60 min. Similarly, responses to mouseTNF were max-
imal in the first 30 min; after 30-60 min mouse TNF was no longer active . Based
on a more detailed time course (Fig . 3 inset) the biological t1/2 of mouse TNF for
oedema formation and cell accumulation was estimated to be 6-7 min . Identical
results were obtained with human recombinant TNF .
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￿
The 30-min flux of
albumin andneutrophils in in-
flammatory lesionsofdifferent
age (0-6 h). Mouse TNF (3 x
10-4 mol/site) or FMLP (5 x
10" mol/site) were injected
intradermallyat different times
(0-360 min, x-axis) before intra-
venous injection of "5I albu-
minand I I IIn neutrophils (zero
time). At this moment all intra-
dermal sites were reinjected
with PGE2 (3 x 10-IO mol/site)
andthereaction wasallowed to
proceed for 30 min. Animals
were killed then by an overdose
of pentobarbitone sodium and
further processed as described
in Materialsand Methods. For
saline-treated sites, the dotted
line shows the background for
plasma leakage, andthedashed
line shows neutrophil accumu-
lation. Results are the mean ±
SEM for six rabbits.
Discussion
TNF is a macrophage-derived peptide that was originally described as the medi-
ator of spontaneous regression of certain tumor cells, discovered in the serum of
endotoxin-treated animals (reviewed in references 8, 9, 13). However, several lines
of evidence indicate that besides cytostatic and cytotoxic activities, TNF may be
an important mediator of inflammation by increasing neutrophil-endothelial cell
adherence (6, 7). The data presented here provide evidence that TNF (already in
very low amounts) has potent pro-inflammatory properties in vivo. Under condi-
tions where localblood flowwas optimally enhanced bythe simultaneous intradermal
injection ofa vasodilator substance (PGE2), both mouse and human TNF induced
neutrophil accumulation andneutrophil-dependent oedema formationin rabbit skin.
Comparable dose-response curves foroedemaformation and neutrophil emigration
were obtained with 0.4-40 U/site of both mouse and human TNF. In view of the
three-fold higher specific activity of mouse TNF (7.5 x 107 U/mg vs. 2.5 x 107
U/mg forhuman TNF), this means thaton a molarbase, mouseTNF is more effec-
tive than human TNF. Therefore, it is possible that TNF receptors on rabbit cells
bind mouse TNF with higher affinity than human TNF.
The fast onset and the short duration ofaction ofTNF in rabbit skin (especially
the absence ofresponses after4-6 h) make ithighly unlikely that TNFinducedneu-
trophilaccumulation involves protein biosynthesis-dependent mechanisms, asreported
for IL-1 (4, 5). The immediate onset ofTNFinduced neutrophil emigration, paral-
leled by an increase in microvascular permeability, more resembles the pro-inflam-
matory profile of chemoattractants (C5a, FMLP, LTB4) that are believed to act
throughactivation ofneutrophils (4, 11). This isfurthersupportedbyfollowingfindings:
(a) TNFinduced oedema formation wasabolishedby neutrophil depletion. (b)TNF
induced oedema formation and cell accumulation were greatly suppressed by infu-RAMPART ET AL.
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sion of PGI2. We have previously provided evidence that in this model PGI2 selec-
tively inhibits neutrophil-dependent responses (12). (c) In vitro, TNF increased the
expression of theCDllb/CD18 glycoproteins, known to be important forneutrophil-
endothelial cell adherence (results not shown). Activation of neutrophills by TNF
is consistent with arecent report from Rothstein and Schreiber(14), that TNRinduced
hemorrhagic necrosis is critically dependent on circulating neutrophils.
It has also been suggested that activation of neutrophils by TNF may require the
production of secondary mediators, such as LTB4 and platelet-activating factor
(PAF). It is unlikely, however, that LTB4 or PAF are mediating the inflammatory
effects of TNF in this model. The duration of action of LTB4 in rabbit skin is much
longer than that of TNF (t112 30 min vs. 6-7 min; Rampart and Williams, unpub-
lished observations); and PAF is a weak chemoattractant in rabbit skin, and PAR
induced oedema formation is independent of neutrophils (15).
The short duration of action of TNF in vivo maybe related to its rapid internali-
zation and degradation after binding to its receptor (16). This short biological half-
life of TNF in vivo may be compensated for by the high amounts of TNF that can
be produced by macrophages (up to 2% of their protein biosynthesis). However,
intradermal injection of much higher amounts of TNF (up to 3 x 10-12 mol/site)
or repeated administration of TNF to the same skin site did not produce larger re-
sponses, suggesting that desensitization to TNF may occurvery rapidly in vivo (un-
published observations).
Finally, intravenousadministration ofTNFto animalsis associated with systemic
activation ofneutrophils, and intratumoral injectionof TNFresults in massiveneu-
trophil infiltration in the tumor (8, 9, 13). To what extent neutrophils are involved
in the elimination of tumor cells by TNF in vivo is unknown at the present time.
There is a large body of in vitro evidence that TNF is directly cytotoxic for many
tumor cell lines, thus, independent of neutrophils (13). Our present data indicate
that activation of neutrophils by TNF can be prevented by an infusion of PG12. It
is tempting to speculate that acombination of antitumor treatment with TNF with
an infusion of PGI2 may suppress some of the undesired side effects of THE Studies
are currently being undertaken to evaluate this hypothesis.
Summary
We have investigated the ability ofrecombinant TNF(mouse and human) to pro-
duce acute inflammatory lesions in an established experimental modelof inflamma-
tion. Upon intradermal injection in rabbit skin, TNF, in amounts as low as 3 x
10-14 mol/site, was found to be very potent at inducing local neutrophil accumula-
tion and neutrophil-dependent oedema formation, thereby fulfilling two important
criteria to be considered as an inflammatory mediator. Our findings further indi-
cate that the pro-inflammatory properties of TNF are probably more related to its
immediate stimulatoryeffectson neutrophils rather than to its slow (protein biosyn-
thesis-dependent effects on endothelial cells. Ourdata thus show that very lowamounts
of mouse and human recombinant TNF can initiate an acute inflammatory reac-
tion in vivo in rabbit skin and that TNF is able to evoke two of the four cardinal
signs of inflammation.
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